// App-Quantinova.ai

TCT40 : 10 mg/L of high-sensitivity C-reactive protein on admission is a powerful predictive marker in patients with ST-segment elevation myocardial infarction, but not in patients with non-ST-segment elevation myocardial infarction

Researchers

Presenter

  • Sungmin Lim

Principal Investigators

  • Byung-Hee Hwang

  • Hee-Yeol Kim

  • Kiyuk Chang

  • Myung Ho Jeong

  • Ki-Bae Seung

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

Biomarkers

  • High sensitivity C-reactive protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved